[go: up one dir, main page]

SE0200119D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE0200119D0
SE0200119D0 SE0200119A SE0200119A SE0200119D0 SE 0200119 D0 SE0200119 D0 SE 0200119D0 SE 0200119 A SE0200119 A SE 0200119A SE 0200119 A SE0200119 A SE 0200119A SE 0200119 D0 SE0200119 D0 SE 0200119D0
Authority
SE
Sweden
Prior art keywords
novel compounds
phenylsulphonamides
pyrazinyl
asthma
formula
Prior art date
Application number
SE0200119A
Other languages
Swedish (sv)
Inventor
Andrew Baxter
Nicholas Kindon
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0200119A priority Critical patent/SE0200119D0/en
Publication of SE0200119D0 publication Critical patent/SE0200119D0/en
Priority to TW092100237A priority patent/TWI328007B/en
Priority to NZ533750A priority patent/NZ533750A/en
Priority to AU2003201802A priority patent/AU2003201802A1/en
Priority to AT03700655T priority patent/ATE534635T1/en
Priority to EP03700655A priority patent/EP1467976B1/en
Priority to IL16267803A priority patent/IL162678A0/en
Priority to JP2003559997A priority patent/JP4504021B2/en
Priority to KR10-2004-7010982A priority patent/KR20040073566A/en
Priority to MXPA04006806A priority patent/MXPA04006806A/en
Priority to ES03700655T priority patent/ES2375107T3/en
Priority to BR0306922-2A priority patent/BR0306922A/en
Priority to PCT/SE2003/000041 priority patent/WO2003059893A1/en
Priority to RU2004119966/04A priority patent/RU2312105C9/en
Priority to HK05101480.0A priority patent/HK1068885B/en
Priority to US10/501,510 priority patent/US7662825B2/en
Priority to PL03371432A priority patent/PL371432A1/en
Priority to UA20040705311A priority patent/UA79255C2/en
Priority to CNB038044811A priority patent/CN100357275C/en
Priority to CA002472204A priority patent/CA2472204A1/en
Priority to ARP030100126A priority patent/AR038179A1/en
Priority to ZA200405260A priority patent/ZA200405260B/en
Priority to IS7348A priority patent/IS7348A/en
Priority to CO04067437A priority patent/CO5640137A2/en
Priority to NO20043370A priority patent/NO20043370L/en
Priority to US12/435,864 priority patent/US20100081670A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides N-pyrazinyl-phenylsulphonamides of formula (I) for use in the treatment of chemokine mediated diseases, in particularly inflammatory diseases, such as asthma. , (I)
SE0200119A 2002-01-16 2002-01-16 Novel compounds SE0200119D0 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
SE0200119A SE0200119D0 (en) 2002-01-16 2002-01-16 Novel compounds
TW092100237A TWI328007B (en) 2002-01-16 2003-01-07 Novel compounds
CA002472204A CA2472204A1 (en) 2002-01-16 2003-01-14 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
PCT/SE2003/000041 WO2003059893A1 (en) 2002-01-16 2003-01-14 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
RU2004119966/04A RU2312105C9 (en) 2002-01-16 2003-01-14 N-pyrazinylphenylsulfonamides and their using in treatment of chemokine-mediated diseases
AT03700655T ATE534635T1 (en) 2002-01-16 2003-01-14 N-PYRAZINYL-PHENYLSULFONAMIDES AND THE USE THEREOF FOR TREATING CHEMOKINE-MEDIATED DISEASES
EP03700655A EP1467976B1 (en) 2002-01-16 2003-01-14 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
IL16267803A IL162678A0 (en) 2002-01-16 2003-01-14 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
JP2003559997A JP4504021B2 (en) 2002-01-16 2003-01-14 N-pyrazinyl-phenylsulfonamides and their use in the treatment of chemokine mediated diseases
KR10-2004-7010982A KR20040073566A (en) 2002-01-16 2003-01-14 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
MXPA04006806A MXPA04006806A (en) 2002-01-16 2003-01-14 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases.
ES03700655T ES2375107T3 (en) 2002-01-16 2003-01-14 N-PIRACINIL-PHENYLSULPHONAMIDES AND ITS USES IN THE TREATMENT OF CHEMIOCINE-MEDIUM DISEASES.
BR0306922-2A BR0306922A (en) 2002-01-16 2003-01-14 N-pyrazinyl phenylsulfonamides and their use in the treatment of chemokine mediated diseases
NZ533750A NZ533750A (en) 2002-01-16 2003-01-14 N-Pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
AU2003201802A AU2003201802A1 (en) 2002-01-16 2003-01-14 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
HK05101480.0A HK1068885B (en) 2002-01-16 2003-01-14 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
US10/501,510 US7662825B2 (en) 2002-01-16 2003-01-14 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
PL03371432A PL371432A1 (en) 2002-01-16 2003-01-14 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
UA20040705311A UA79255C2 (en) 2002-01-16 2003-01-14 N-pyrazinyl-phenylsulphonamides, process for the preparation thereof (variants), pharmaceutical composition based thereon, process for the preparation thereof, method for treatment of chemokine mediated disease, method for treatment of inflammatory disease
CNB038044811A CN100357275C (en) 2002-01-16 2003-01-14 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
ARP030100126A AR038179A1 (en) 2002-01-16 2003-01-16 PHENYLSULPHONAMIDS FOR THERAPEUTIC USE
ZA200405260A ZA200405260B (en) 2002-01-16 2004-07-01 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases.
IS7348A IS7348A (en) 2002-01-16 2004-07-08 N-pyrazinyl-phenylsulfonamide and their use in the treatment of cerebrovascular diseases
CO04067437A CO5640137A2 (en) 2002-01-16 2004-07-15 N-PIRAZINIL-PHENYLSULPHONAMIDES AND ITS USE IN THE TREATMENT OF CHEMOSINE MEDIUMED DISEASES
NO20043370A NO20043370L (en) 2002-01-16 2004-08-13 N-pyrazinylphenylsulfonamides and their use in the treatment of chemokine-mediated diseases
US12/435,864 US20100081670A1 (en) 2002-01-16 2009-05-05 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0200119A SE0200119D0 (en) 2002-01-16 2002-01-16 Novel compounds

Publications (1)

Publication Number Publication Date
SE0200119D0 true SE0200119D0 (en) 2002-01-16

Family

ID=20286679

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0200119A SE0200119D0 (en) 2002-01-16 2002-01-16 Novel compounds

Country Status (3)

Country Link
SE (1) SE0200119D0 (en)
UA (1) UA79255C2 (en)
ZA (1) ZA200405260B (en)

Also Published As

Publication number Publication date
UA79255C2 (en) 2007-06-11
ZA200405260B (en) 2005-10-03

Similar Documents

Publication Publication Date Title
AU2002358390A1 (en) Novel compounds
UA85559C2 (en) Aminobenzophenone compounds
ATE267830T1 (en) SULFONYLPHENYLPYRAZOLE COMPOUNDS USABLE AS COX INHIBITORS
SE0301700D0 (en) Novel compounds
BRPI0418251A (en) phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases
NO20062561L (en) Quinolines useful for the treatment of cardiovascular diseases
UA83875C2 (en) Quinoline derivatives for use as mycobacterial inhibitors
DE60230890D1 (en) INDOLICINE AS KINASEPROTEINHEMMER
ECSP055640A (en) PIRAZOL COMPOSITIONS USEFUL AS INHIBITORS OF GSK-3
NO20082594L (en) Pyrimidinylbenzotiofenforbindelser
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
MX2007003108A (en) Substituted bicyclic imidazo-3-ylamine compounds.
ATE448232T1 (en) SUBSTITUTED HETEROCYCLES
BR0306922A (en) N-pyrazinyl phenylsulfonamides and their use in the treatment of chemokine mediated diseases
NO20043016L (en) 6-aminomorphinan derivatives, process for preparation and use thereof
MX2007011695A (en) Substituted oxindole derivatives, medicaments containing the latter and use thereof.
SE0302304D0 (en) Novel compounds
UA90698C2 (en) Triazole substituted aminobenzophenone compounds
NO20055741D0 (en) New chemical compounds
SE0102716D0 (en) Novel compounds
ATE419242T1 (en) PYRROLIDINYLUREA DERIVATIVES AS ANGIOGENESIS INHIBITORS
DE60316128D1 (en) N-sulfonylurea APOPTOSIS PROMOTERS
IL189286A0 (en) Novel cysteine protease inhibitors and their therapeutic applications
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
EA200800342A1 (en) Glepp-1 INHIBITORS FOR THE TREATMENT OF AUTOIMMUNE AND / OR INFLAMMATORY DISORDERS